PRNewsWire
30 Dec 2025, 14:30 UTC · 37w ago
Verdict
Headline leans bearish. We score INSP −1.00 across five claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−1.00strongly bearish
What the story claims
5 claims · scored −1 bearish … +1 bullish
Inspire Medical Systems slashed its 2025 EPS guidance by over 80% following a flawed Inspire V product launch.
So whatA massive guidance cut of this magnitude directly impacts valuation and indicates a severe breakdown in revenue expectations.
More negative than 99% of claims this week
A securities class action lawsuit alleges that Inspire Medical concealed Medicare billing software failures and an inventory glut of older devices.
Continue reading
5 related stories
More negative than 96% of ticker scores this week
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More negative than 92% of claims this week
Medicare claims processing software updates were delayed until July 1, 2025, preventing implanting centers from billing for procedures.
More negative than 87% of claims this week
An excess inventory of the older Inspire IV device created a 'channel glut,' reducing immediate demand for the new Inspire V product.
More negative than 81% of claims this week
Many treatment centers failed to complete the essential training and onboarding required to implant the Inspire V device.
More negative than 73% of claims this week
Which stocks this story touches
More negative than 96% of ticker scores this week
The company is facing a securities fraud class action lawsuit following a significant stock price drop and allegations of concealing operational failures.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
−17.8%
Price agrees with the score
$76.96 vs $93.67 close before publication (Dec 29) · not market-adjusted
INSP chart →
